Keywords: roche, terminates, pdl, daclizumab, accord, swiss, drug

Roche terminates PDL daclizumab accord

Article | 27 November 2006

Print This

Swiss drug major Roche says it will discontinue its agreement with US drugmaker PDL BioPharma to jointly develop and commercialize ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in